Breast cancer (BC) remains a significant health burden worldwide, necessitating the
development of innovative therapeutic strategies. The B-cell lymphoma 2 (Bcl-2) family …

Cancer presents a formidable threat to human health, with the majority of cases currently
lacking a complete cure. Frequently, chemotherapy drugs are required to impede its …

Drug resistance remains a critical barrier in cancer therapy, diminishing the effectiveness of
chemotherapeutic, targeted, and immunotherapeutic agents. Overexpression of proteins …

Ureteral stenting is a common clinical procedure for the treatment of upper urinary tract
disorders, including conditions such as urinary tract infections, tumors, stones, and …

Introduction The study aimed to develop a nano-based drug delivery system for the
treatment of hepatocellular carcinoma (HCC), a type of liver cancer that accounts for 90% of …

The recent development of nanotechnology-based formulations improved the diagnostics
and therapies for various diseases including cancer where lack of specificity, high …

Cancer has arisen from both genetic mutations and epigenetic changes, making epigenetics
a crucial area of research for innovative cancer prevention and treatment strategies. This …

Breast cancer is the most common malignant tumour in women worldwide, as well as the
leading cause of death from malignant tumours. All across the world, the incidence of breast …

Acute myeloid leukemia (AML), a heterogeneous hematopoietic cancer prevalent in adults,
has been a leading cause of leukemia-associated deaths for decades. Despite …

Hematologic malignancies (HMs), also referred to as hematological or blood cancers, pose
significant threats to patients as they impact the blood, bone marrow, and lymphatic system …